Cancer – ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors
Condition or Therapy:
Germ cell tumor, germinoma
Cancer and Blood Disorders
Study Number: ACNS1123
What is the goal of this study?
This study looks at how well chemotherapy followed by radiation therapy works in treating patients with newly diagnosed central nervous system germ cell tumors that have not spread to other parts of the brain, spine or body.
Who can join the study?
This study may be a good fit for children and young adults who:
- are 3 to 21 years old and
- are newly diagnosed with localized childhood central nervous system germinoma.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.